Related Experiment Video
Updated: Aug 20, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
[The clinical case of the month. Malignant whooping cough in an infant]
O Wauters1, D Brumioul, J P Sacré
1Département Universitaire de Pédiatrie, Liège.
Insights
Despite vaccination, infant whooping cough (pertussis) remains a serious concern. This case highlights pertussis complications in a vaccinated infant, underscoring the need for ongoing vigilance and research.
Area of Science:
- Pediatrics
- Infectious Diseases
- Immunology
Background:
- Whooping cough (pertussis) continues to pose significant morbidity and mortality risks to infants globally.
- Current vaccination strategies aim to reduce pertussis incidence, but breakthrough cases occur.
- Infants are particularly vulnerable due to their immature immune systems.
Observation:
- This report details a clinical case of a 3-month-old infant diagnosed with pertussis.
- The infant had received a primary dose of the anti-pertussis vaccine at 2 months and 3 weeks of age.
- The case involved significant complications, necessitating medical intervention.
Findings:
- Pertussis can manifest with severe complications even after partial vaccination in infants.
- The timing and efficacy of the initial vaccine dose may not always prevent severe disease.
- Clinical presentation and complications require careful monitoring in young infants.
Implications:
- This case underscores the importance of recognizing pertussis in vaccinated infants presenting with severe symptoms.
- It highlights potential gaps in vaccine-induced immunity or the need for booster strategies in early infancy.
- Further research into infant immune responses and optimal pertussis prevention is warranted.
Abstract:
Morbidity and mortality of whooping cough remain significant among infants despite vaccination. This article presents a case of whooping cough with complications in a 3 month old infant who had already received his first dose of anti-pertussis vaccine at 2 months and 3 weeks of age.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Respiratory Syncytial Virus Disease
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology